LINC01170 promotes the progression of endometrial carcinoma by activating the AKT pathway.

Zhengzheng Zhang, Xiao Liu, Hao Xu, Pan Li, Tian Zeng, Wensheng Du, Xiaoyuan LuPubMed 2019

Abstract

LINC01170 promotes the progression of endometrial carcinoma through stimulating proliferation, cell cycle transition and inhibiting apoptosis of endometrial carcinoma cells via AKT pathway.
BibTeX
@inproceedings{zhang2019linc,
  author = {Zhengzheng Zhang and Xiao Liu and Hao Xu and Pan Li and Tian Zeng and Wensheng Du and Xiaoyuan Lu},
  title = {{LINC01170 promotes the progression of endometrial carcinoma by activating the AKT pathway.}},
  booktitle = {PubMed},
  year = {2019},
}

Loading related content...

Figure